Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
Status:
Terminated
Trial end date:
2019-05-09
Target enrollment:
Participant gender:
Summary
The goal of this single arm Phase I feasibility study is to investigate the tolerability of
cannabis with concurrent chemoradiation in the treatment of glioblastoma multiforme (GBM). A
strain of cannabis provided by The National Institute of Drug Abuse (NIDA) that has a high
concentration of cannabidiol (CBD) and a low concentration of THC (relative to average street
cannabis) will be tested in order to maximize clinical efficacy while minimizing intoxicating
side effects in this medically-ill population.